54 results  1 of 3 

1 A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)
Dae-Won Lee, Bhumsuk Keam, Keun Seok Lee, Jin-Hee Ahn, Joohyuk Sohn, Jin Seok Ahn, Moon Hee Lee, Jee Hyun Kim, Kyung Eun Lee, Hyo Jung Kim, Si-Young Kim, Yeon Hee Park, Chan-Young Ock, Kyung-Hun Lee, Sae-Won Han, Sung-Bae Kim, Young Hyuck Im, Hyun Cheol Chung, Do-Youn Oh, Seock-Ah Im
Cancer Res Treat.2023;55(2):523-530.   Published online 2022 November 8     DOI: http://dx.doi.org/10.4143/crt.2022.1360
      
2 5-HT1A receptors mediate the analgesic effect of rosavin in a mouse model of oxaliplatin-induced peripheral neuropathic pain
Daxian Li, Sangwon Park, Kyungjoon Lee, Dae Sik Jang, Sun Kwang Kim
Korean J Physiol Pharmacol.2021;25(5):489-494.   Published online 2021 September 1     DOI: http://dx.doi.org/10.4196/kjpp.2021.25.5.489
      
3 Adjuvant oxaliplatin-based chemotherapy effect after treatment of colorectal hepatic metastasis
Mee-Young Kang, Jin-Hee Paik, Chun-Geun Ryu, Dae-Yong Hwang
Ann Surg Treat Res.2021;101(3):160-166.   Published online 2021 August 31     DOI: http://dx.doi.org/10.4174/astr.2021.101.3.160
      
4 Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
Toshikazu Moriwaki, Masahiko Gosho, Akinori Sugaya, Takeshi Yamada, Yoshiyuki Yamamoto, Ichinosuke Hyodo
Cancer Res Treat.2021;53(3):703-713.   Published online 2020 December 1     DOI: http://dx.doi.org/10.4143/crt.2020.805
      
5 췌장암 환자에서 Oxaliplatin 사용 후 발생한 돌발성 난청 1예
Sung Bum Kim, So Yeong Kim, Kook Hyun Kim, Tae Nyeun Kim
Korean J Gastroenterol.2020;76(5):261-264.   Published online 2020 November 25     DOI: http://dx.doi.org/10.4166/kjg.2020.121
      
6 Is platelet-rich plasma improves the anastomotic healing in hyperthermic intraperitoneal chemotherapy with oxaliplatin: an experimental rat study
Omer Faruk Buk, Sonmez Ocak, Bugra Genc, Bahattin Avcı, Hatice Olger Uzuner
Ann Surg Treat Res.2020;98(2):89-95.   Published online 2020 January 31     DOI: http://dx.doi.org/10.4174/astr.2020.98.2.89
      
7 Oxaliplatin-induced Peripheral Neuropathy, Symptoms, Distress and Quality of Life among Korean Patients with Gastrointestinal Cancer
Hye Jeong Jung, Soo jung Ahn, Yoo Ri Yang, Kyoung A Kim, Sang Joon Shin, Min Kyu Jung, Sang Hui Chu
Asian Oncol Nurs.2019;19(4):204-213.   Published online 2019 December 31     DOI: http://dx.doi.org/10.5388/aon.2019.19.4.204
      
8 Choice of Capecitabine or S1 in Combination with Oxaliplatin based on Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients with Advanced Gastric Cancer
Rong Xu, Xiaolei He, Reyina Wufuli, Ying Su, Lili Ma, Ru Chen, Zhongcheng Han, Fang Wang, Jiang Liu
J Gastric Cancer.2019;19(4):408-416.   Published online 2019 November 13     DOI: http://dx.doi.org/10.5230/jgc.2019.19.e40
      
9 Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo
Cancer Res Treat.2020;52(1):254-262.   Published online 2019 July 9     DOI: http://dx.doi.org/10.4143/crt.2019.190
      
10 Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
Jiyoung Rhee, Jaemin Jo, Sang-Hoon Han, Jung-Mi Kwon
Ann Dermatol.2019;31(2):201-203.   Published online 2019 February 28     DOI: http://dx.doi.org/10.5021/ad.2019.31.2.201
      
11 Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer
Jeonghyun Kang, Joon Seong Park, Sung Gwe Ahn, Jin Hong Lim, Seung Hyuk Baik, Dong Sup Yoon, Kang Young Lee, Joon Jeong
Ann Surg Treat Res.2018;95(3):161-167.   Published online 2018 August 31     DOI: http://dx.doi.org/10.4174/astr.2018.95.3.161
      
12 Analysis of reduced-dose administration of oxaliplatin as adjuvant FOLFOX chemotherapy for colorectal cancer
Dawon Park, Se-Jin Baek, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim
Ann Surg Treat Res.2018;94(4):196-202.   Published online 2018 March 26     DOI: http://dx.doi.org/10.4174/astr.2018.94.4.196
      
13 Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang
Cancer Res Treat.2018;50(4):1324-1330.   Published online 2018 January 8     DOI: http://dx.doi.org/10.4143/crt.2017.526
      
14 A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
Su-Hyun Kim, Woojun Kim, Ji-Hee Kim, Min Ki Woo, Ji Yeon Baek, Sun Young Kim, Seung Hyun Chung, Ho Jin Kim
J Clin Neurol.2018;14(1):81-89.   Published online 2017 December 27     DOI: http://dx.doi.org/10.3988/jcn.2018.14.1.81
      
15 Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates
Sung-Hye You, Beom Jin Park, Yeul Hong Kim
Korean J Radiol.2017;18(3):413-426.   Published online 2017 April 3     DOI: http://dx.doi.org/10.3348/kjr.2017.18.3.413
      
16 Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis
Vikas Ostwal, Arvind Sahu, Anant Ramaswamy, Bhawna Sirohi, Subhadeep Bose, Vikas Talreja, Mahesh Goel, Shraddha Patkar, Ashwin Desouza, Shailesh V. Shrikhande
J Gastric Cancer.2017;17(1):21-32.   Published online 2017 March 16     DOI: http://dx.doi.org/10.5230/jgc.2017.17.e3
      
17 Modified FOLFOX-6 Chemotherapy for Recurrent or Inoperable Gastric Cancer Patients
Sung Bae Jee, Jae Hyun Han, Hoon Huh, Kyo Young Song, Hyung Min Chin, Wook Kim, Cho Hyun Park, Seung Man Park, Seung Nam Kim, Hae Myung Jeon
J Korean Gastric Cancer Assoc.2008;8(1):40-46.   Published online 2017 March 11     DOI: http://dx.doi.org/10.5230/jkgca.2008.8.1.40
   
18 Silencing the livin gene enhances the cytotoxic effects of anticancer drugs on colon cancer cells
Bo Young Oh, Kwang Ho Kim, Soon Sup Chung, Ryung-Ah Lee
Ann Surg Treat Res.2016;91(6):273-277.   Published online 2016 November 25     DOI: http://dx.doi.org/10.4174/astr.2016.91.6.273
      
19 Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen
Changhoon Yoo, Bum Jun Kim, Kyu-pyo Kim, Jae-Lyun Lee, Tae Won Kim, Baek-Yeol Ryoo, Heung-Moon Chang
Cancer Res Treat.2017;49(3):759-765.   Published online 2016 November 9     DOI: http://dx.doi.org/10.4143/crt.2016.371
      
20 Involvement of spinal muscarinic and serotonergic receptors in the anti-allodynic effect of electroacupuncture in rats with oxaliplatin-induced neuropathic pain
Ji Hwan Lee, Donghyun Go, Woojin Kim, Giseog Lee, Hyojeong Bae, Fu Shi Quan, Sun Kwang Kim
Korean J Physiol Pharmacol.2016;20(4):407-414.   Published online 2016 June 23     DOI: http://dx.doi.org/10.4196/kjpp.2016.20.4.407
      

 1 of 3